About GW Pharma
GW Pharma is a company based in Cambridge (United Kingdom) founded in 1998 was acquired by Jazz Pharmaceuticals in February 2021. GW Pharma has raised $46.5 million across 3 funding rounds from investors including Jazz Pharmaceuticals and Mentor Capital. GW Pharma offers products and services including Xywav, Epidiolex, Defitelio, and Rylaze. GW Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, PureTech Health and Biohaven Pharmaceutical, among others.
- Headquarter Cambridge, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gw Pharma Limited
- Date of Incorporation 29 Jan, 1999
- Jurisdiction CAMBRIDGE
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$46.5 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Post-IPO
Mar 03, 2017
-
Investors
Jazz Pharmaceuticals
& 1 more
-
Employee Count
Not available
-
Acquired by
Jazz Pharmaceuticals
(Feb 03, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GW Pharma
GW Pharma offers a comprehensive portfolio of products and services, including Xywav, Epidiolex, Defitelio, and Rylaze.
Oral solution for treating narcolepsy and idiopathic hypersomnia
Cannabidiol-based treatment for epilepsy seizures
Therapy for preventing complications in leukemia patients
Recombinant treatment for acute lymphoblastic leukemia
People of GW Pharma
Unlock access to complete
Unlock access to complete
Leadership Team
223 people
Software Development Team
103 people
Sales and Marketing
70 people
Senior Team
66 people
Product Management Team
56 people
Finance and Accounting
37 people
Data Analysis and Operations Team
31 people
Human Resources and Administration
30 people
Unlock access to complete
Funding Insights of GW Pharma
GW Pharma has successfully raised a total of $46.5M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GW Pharma
GW Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Jazz Pharmaceuticals and Mentor Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Energy investments and funding for pre-IPO companies in oil, gas, coal, and uranium sectors.
|
Locked | Locked | Locked | |
|
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
Locked | Locked | Locked |
Investor details for GW Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GW Pharma
Investment portfolio details for GW Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GW Pharma
Detailed financials for GW Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gw Pharma Comparisons
Peer comparison for GW Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GW Pharma
GW Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, PureTech Health and Biohaven Pharmaceutical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| Locked | Locked | Locked |
Therapies for psychosis and cognitive impairment are developed.
|
Detailed competitors of GW Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gw Pharma
Complete news archive for GW Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GW Pharma
GW Pharma was founded in 1998 and raised its 1st funding round 5 years after it was founded.
GW Pharma is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
GW Pharma is a funded company, having raised a total of $46.5M across 3 funding rounds to date.
GW Pharma was founded in 1998 in Cambridge, United Kingdom, within the pharmaceutical sector. Focus is placed on developing cannabinoid-based treatments, including Sativex for managing spasticity in multiple sclerosis patients and pain in cancer cases, as well as Epidiolex for addressing epilepsy in children. Operations center on research and drug approval processes across Europe and beyond, targeting neurological and pain-related conditions.
GW Pharma's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
GW Pharma offers Xywav, Epidiolex, Defitelio, and Rylaze.
GW Pharma has 2 investors. Key investors include Jazz Pharmaceuticals, and Mentor Capital.